MedTrace Logo

Drug Use Investigation (DUI) of YazFlex for Endometriosis-associated Pelvic Pain and/or Dysmenorrhea

NCT03126747 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 715

Last updated 2022-11-16

No results posted yet for this study

Summary

This study is a Japanese post-marketing surveillance (PMS) which is required by the regulatory authorities. General objective of PMS is to confirm the clinical usefulness, especially the safety profile of a drug under the routine clinical practice.

Conditions

  • Endometriosis and Dysmenorrhea

Interventions

DRUG

BAY86-5300_YAZ-Flex

Patients with endometriosis-associated pelvic pain and/or dysmenorrhea are enrolled solely after the physician's decision of YazFlex treatment in routine clinical practice.

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-29
Primary Completion
2021-06-17
Completion
2021-11-17

Countries

  • Japan

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03126747 on ClinicalTrials.gov